Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Li-Tzong Chen"'
Autor:
Yuichi Ichinose, Yi-Hsin Yang, Hui-Jen Tsai, Ru-Yu Huang, Takahiro Higashi, Toshirou Nishida, Li-Tzong Chen
Publikováno v:
Scientific reports. 12(1)
Tyrosine kinase inhibitors (TKIs) improve the prognosis of patients with gastrointestinal stromal tumors (GISTs). We conducted a retrospective cohort study using cancer registries linked with health utilization data in Japan and Taiwan to assess TKI
Autor:
Li-Tzong Chen, Taroh Satoh, Keisho Chin, Takaki Yoshikawa, Yee Chao, Masahiro Tsuda, Hyun Cheol Chung, Keun Wook Lee, Keiko Minashi, Min Hee Ryu, Jong Gwang Kim, Yoon-Koo Kang, Jae Yong Cho, Ken Kato, Narikazu Boku, Won Ki Kang, Takao Tamura, Do Youn Oh, Kun-Huei Yeh, Li Yuan Bai, Yasuo Hamamoto, Taihei Nishiyama, Jen-Shi Chen, Kei Muro, Sang Cheul Oh
Publikováno v:
Gastric Cancer
Background ATTRACTION-2 demonstrated that nivolumab improved overall survival (OS) vs placebo in patients with advanced gastric cancer treated with ≥ 2 chemotherapy regimens. However, its long-term efficacy and outcome of treatment beyond progressi
Autor:
Li-Yuan Bai, Chung-Pin Li, Yan-Shen Shan, Shih-Chang Chuang, Jen-Shi Chen, Nai-Jung Chiang, Yen-Yang Chen, Hsiao-Hui Tsou, Mei-Hsing Chuang, Chang-Fang Chiu, Tsang-Wu Liu, Li-Tzong Chen
Publikováno v:
European journal of cancer (Oxford, England : 1990). 173
Elderly patients with advanced pancreatic adenocarcinoma (APC) are conceived to be frailer and susceptible to treatment toxicity that has led to disparity in lower likelihood of receiving chemotherapy and survival. Optimal chemotherapy is an unmet me
Autor:
Bruce Belanger, Chung Pin Li, Joon Oh Park, Jen-Shi Chen, Li-Tzong Chen, Chang Fang Chiu, Kun Ming Rau, Hyun Jeong Shim, Yung-Jue Bang, Do Youn Oh, Hye Jin Choi, Yan Shen Shan, Jun Suk Kim, Kyung Hun Lee
Publikováno v:
Cancer Science
The global, randomized NAPOLI‐1 phase 3 trial reported a survival benefit with liposomal irinotecan (nal‐IRI) plus 5‐fluorouracil/leucovorin (nal‐IRI+5‐FU/LV) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after previo
Autor:
Li-Tzong Chen, Hiroki Sameshima, Li Yuan Bai, Takao Tamura, Min Hee Ryu, Narikazu Boku, Do Youn Oh, Masahiro Tsuda, Keisho Chin, Yee Chao, Taroh Satoh, Keun Wook Lee, Takaki Yoshikawa, Keiko Minashi, Hyun Cheol Chung, Kun-Huei Yeh, Jae Yong Cho, Sang Cheul Oh, Jong Gwang Kim, Won Ki Kang, Ken Kato, Yasuo Hamamoto, Kei Muro, Yoon-Koo Kang, Jen-Shi Chen
Publikováno v:
Gastric Cancer. 23:510-519
Background Nivolumab showed improvement in overall survival (OS) in ATTRACTION-2, the first phase 3 study in patients with gastric/gastroesophageal junction (G/GEJ) cancer treated with ≥ 2 chemotherapy regimens. The 2-year follow-up results of ATTR
Autor:
Hung-Chi Chang, Yee Chao, Tsang Wu Liu, Jen-Shi Chen, Anna Fen-Yau Li, Li-Tzong Chen, Ming-Shiang Wu, Yi-Hsin Yang, Huang-Ming Hu, Hsiu-Po Wang, Hui-Jen Tsai, Li Yuan Bai, Tsang-En Wang, Chun-Ju Chiang, Shu-chen Chen, Su-Shun Lo, Yan Shen Shan, Hsiu-Ying Ku
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Chemotherapy is generally considered as the main treatment for metastatic gastric adenocarcinoma. The role of gastrectomy for metastatic gastric cancer without obvious symptoms is controversial. The objective of this study is to investigate survival
Autor:
Yoon-Koo Kang, Li-Tzong Chen, Min-Hee Ryu, Do-Youn Oh, Sang Cheul Oh, Hyun Cheol Chung, Keun-Wook Lee, Takeshi Omori, Kohei Shitara, Shinichi Sakuramoto, Ik-Joo Chung, Kensei Yamaguchi, Ken Kato, Sun Jin Sym, Shigenori Kadowaki, Kunihiro Tsuji, Jen-Shi Chen, Li-Yuan Bai, Sung-Yong Oh, Yasuhiro Choda, Hisateru Yasui, Kentaro Takeuchi, Yoshinori Hirashima, Shunsuke Hagihara, Narikazu Boku
Publikováno v:
The Lancet. Oncology. 23(2)
The additive or synergistic sustained antitumour effect of immune checkpoint inhibitors in combination with oxaliplatin-based chemotherapy has previously been reported. We investigated the efficacy of nivolumab plus oxaliplatin-based chemotherapy ver
Autor:
Huei-Lan Lee, Li-Tzong Chen, Ming-Yen Lin, Shang-Jyh Hwang, Wen-Jeng Wu, Sheng-Wen Niu, Wei-Ming Li
Publikováno v:
International journal of urology : official journal of the Japanese Urological Association. 29(2)
To assess temporal patterns and regional differences in the incidence rate, and factors associated with survival of urinary tract urothelial carcinoma.The medical records of 8830 patients with new diagnoses of urinary tract urothelial carcinoma in th
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
The incidence of neuroendocrine tumors (NETs) has been increasing in recent decades. Previously, we reported the incidence and survival of NETs in Taiwan by analyzing the 1996–2008 data from the Taiwan Cancer Registry. Here we performed an updated
Autor:
Li-Tzong Chen, Juan W. Valle, Philip J. Ebert, Arndt Vogel, Thomas J. Ettrich, Wei Zhang, Do-Youn Oh, Eric Van Cutsem, Amit Aggarwal, Rashida Orlova, Allicia C. Girvan, Jorge Adeva, Chunlao Tang, Harpreet Wasan, Li Yuan Bai, Jiangang Liu, Joana M Oliveira, Radka Obermannova, Roberto Carlesi, Aiwu Ruth He, Richard A. Walgren, Crystal S. Denlinger, Samuel McNeely, Jen-Shi Chen, Brian A. Moser
Publikováno v:
The Lancet. Oncology. 22(10)
Summary Background Biliary tract cancers are aggressive, rare, gastrointestinal malignancies with a poor prognosis; approximately half of patients with these cancers survive for less than 1 year after diagnosis with advanced disease. We aimed to eval